Coagulation and fibrinolytic parameters in normal pregnancy and in pregnancy complicated by intrauterine growth retardation

被引:43
作者
Bellart, J [1 ]
Gilabert, R [1 ]
Fontcuberta, J [1 ]
Carreras, E [1 ]
Miralles, RM [1 ]
Cabero, L [1 ]
机构
[1] Hosp Univ Tarragona Joan XXIII, Serv Ginecol & Obstset, Unitat Med Materno Fetal, E-43007 Tarragona, Spain
关键词
coagulation; fibrinolysis; pregnancy; intrauterine growth retardation;
D O I
10.1055/s-2007-993903
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
The objective of this article is to evaluate the plasma levels of coagulation and fibrinolysis parameters in the third trimester of gestation and 72 hr postdelivery. Antithrombin III (ATIII), thrombin-antithrombin III complexes (TAT), heparin cofactor II (HCII), protein C (PC), protein S (PS), tissue plasminogen activator (t-PA), D-dimer, and plasminogen activator inhibitors (PAI-1 and PAI-2) levels in uncomplicated pregnancies and in pregnancies complicated by intrauterine growth retardation (IUGR) have been determined. Normal pregnant women (n = 63) and women whose was complicated by IUGR (n = 10) formed the study population. Coagulation and fibrinolysis parameters were estimated using comercial tests. There were no differences in ATIII, HCII, and PS levels between normal and IUGR pregnancies. TAT, t-PA, and D-dimer levels were higher in IUGR pregnancy than in the uncomplicated pregnancy group. PAI-1 and PAI-2 were found depressed in IUGR pregnancy when compared with normal pregnancy. Changes in coagulation and fibrinolytic systems occur in plasma of women with pregnancies complicated by IUGR. The results suggest an activation of the coagulation system in pregnancies complicated by IUGR. Reduced PAI-2 and high TAT levels correlate with birth weight. In IUGR pregnancies a hypercoagulative state with hyperfibrinolytic compensatory mechanisms is suggested.
引用
收藏
页码:81 / 85
页数:5
相关论文
共 17 条
  • [1] AN ANTICOAGULANT DERMATAN SULFATE PROTEOGLYCAN CIRCULATES IN THE PREGNANT WOMAN AND HER FETUS
    ANDREW, M
    MITCHELL, L
    BERRY, L
    PAES, B
    DELORME, M
    OFOSU, F
    BURROWS, R
    KHAMBALIA, B
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (01) : 321 - 326
  • [2] BACHMANN F, 1995, THROMB HAEMOSTASIS, V74, P172
  • [3] BALLEGEER V, 1987, THROMB HAEMOSTASIS, V58, P1030
  • [4] Fibrinolysis changes in normal pregnancy
    Bellart, J
    Gilabert, R
    Fontcuberta, J
    Borrell, M
    Miralles, RM
    Cabero, L
    [J]. JOURNAL OF PERINATAL MEDICINE, 1997, 25 (04) : 368 - 372
  • [5] CHANGES IN THE FIBRINOLYTIC SYSTEM DURING PREGNANCY
    BONNAR, J
    DALY, L
    SHEPPARD, BL
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1990, 16 (03) : 221 - 229
  • [6] BREMME K, 1992, OBSTET GYNECOL, V80, P132
  • [7] PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-2 INHIBITS TUMOR-NECROSIS-FACTOR-ALPHA-INDUCED APOPTOSIS - EVIDENCE FOR AN ALTERNATE BIOLOGICAL FUNCTION
    DICKINSON, JL
    BATES, EJ
    FERRANTE, A
    ANTALIS, TM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (46) : 27894 - 27904
  • [8] COAGULATION AND FIBRINOLYSIS IN PREGNANCIES COMPLICATED BY FETAL GROWTH RETARDATION
    ELDER, MG
    MYATT, L
    [J]. BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1976, 83 (05): : 355 - 360
  • [9] DETERMINATION OF TOTAL, FREE AND COMPLEXED PROTEIN-S IN PLASMA BY ELISA, AND COMPARISON WITH A STANDARD ELECTROIMMUNOASSAY
    ESPANA, F
    HENDL, S
    AZNAR, J
    GILABERT, J
    ESTELLES, A
    [J]. THROMBOSIS RESEARCH, 1991, 62 (06) : 615 - 624
  • [10] FIBRINOLYTIC PARAMETERS IN NORMOTENSIVE PREGNANCY WITH INTRAUTERINE FETAL GROWTH-RETARDATION AND IN SEVERE PREECLAMPSIA
    ESTELLES, A
    GILABERT, J
    ESPANA, F
    AZNAR, J
    GALBIS, M
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1991, 165 (01) : 138 - 142